Evidence map›Paper›PMID 36276450›Full record

Article3 Biotech2022

Separation of closely related monoclonal antibody charge variant impurities using poly(ethylenimine)-grafted cation-exchange chromatography resin.

Ganesh T Sivanathan, Hanuman Mallubhotla, Satyanarayana V Suggala, Manikanta Sriharsha Tholu

Open access · greenAbstract read
In one paragraph

Article in 3 Biotech, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
0.3field-weighted citation impact, top 44% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed, 4 citations in OpenAlex.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 2 institutions in 1 country.

Ganesh T SivanathanDepartment of Chemical Engineering, JNTUA, Ananthapuramu, Andhra Pradesh 515002 India.ORCID 0000-0001-7897-0515
Hanuman MallubhotlaBiopharmaceutical Development, Syngene International Ltd., Bangalore, 560099 India.
Satyanarayana V SuggalaDepartment of Chemical Engineering, JNTUA, Ananthapuramu, Andhra Pradesh 515002 India.
Manikanta Sriharsha TholuBiopharmaceutical Development, Syngene International Ltd., Bangalore, 560099 India.
Syngene International (India) · INJawaharlal Nehru Technological University Anantapur · IN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The removal of protein charge variants due to complex chemical and enzymatic modifications like glycosylation, fragmentation and deamidation presents a significant challenge in the purification of monoclonal antibodies (mAb) and complicates downstream processing. These protein modifications occur either in vivo or during fermentation and downstream processing. The presence of charge variants can lead to diminished biological activity, differences in pharmacokinetics, pharmacodynamics, stability and efficacy. Therefore, these different product variants should be appropriately controlled for the consistency of product quality and to ensure patient safety. This investigation focuses on the development of a chromatography step for the removal of the charge variants from a recombinant single-chain variable antibody fragment (scFv-Fc-Ab). Poly(ethyleneimine)-grafted cation-exchange resins (Poly CSX and Poly ABX) were evaluated and compared to traditional macroporous cation-exchange and tentacle cation-exchange resins. Linear salt gradient experiments were conducted to study the separation efficiency of scFv-Fc-Ab variants using different resins. A classical thermodynamic model was used to develop a mechanistic understanding of the differences in charge variant retention behaviour of different resins. High selectivity in separation of scFv-Fc-Ab charge variants is obtained in the Poly CSX resin.

Indexed as

Cation-exchange chromatographyCharge variantsLGE modelLinear gradient elutionMulti modal chromatographyPoly ABXPoly CSXscFv−Fc−AbSingle-chain variable antibody fragmentThermodynamic model

Identifiers

PMID36276450
PMCPMC9515282
OpenAlexW4297319394

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.